| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911311 | Lung Cancer | 2012 | 7 Pages |
Abstract
The results of this study indicate that EGFR and HER2 amplification is a rare event in thymic carcinoma, however, protein expression for HER receptors as well as their ligands is a common finding indicating that targeted therapy directed against these molecules may be considered in the treatment of these tumors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Annikka Weissferdt, Heather Lin, Denise Woods, Ximing Tang, Junya Fujimoto, Ignacio I. Wistuba, Cesar A. Moran,